Preventive Care
Latest News
Prophylactic meds may prevent cesarean bleeding
“As methylergonovine is a known contraindication to hypertensive and cardiovascular disorders, patients would have to be carefully screened.”
From the Journals
Primer message boosts colorectal cancer screening rates
Sending adults an electronic notification prior to mailing a fecal immunochemical test improves rates of test completion.
Latest News
AHA annual stats update highlights heart-brain connection
“The global rate of brain disease is quickly outpacing heart disease.”
Feature
Dr. Jeremiah Stamler, pioneer of preventive cardiology, dies at 102
The internationally renowned physician’s research altered the way the world views diet and heart health, and influenced public health policy for...
From the Journals
Vitamin D shows no survival benefit in nondeficient elderly
“This is not dissimilar to research with many other nutrients showing that increasing intake above the adequate intake has no further health...
Latest News
A dermatologist-led model for CVD prevention in psoriasis may be feasible
The researchers see their findings as an early but promising step in finding better models to improve cardiovascular outcomes for patients with...
Latest News
Moderna launches clinical trials for HIV vaccine
The vaccine is designed to prompt white blood cells to turn into antibodies that can neutralize HIV.
From the Journals
‘Physiology fights back’ when people are trying to lose weight
“Individuals who are struggling to achieve weight-loss goals, despite assuring compliance with [a] diet, may indeed be ‘suffering’ from metabolic...
From the Journals
Early, subtle, cardiac changes tied to midlife cognitive decline
Researchers said that “heart health is key to brain health.”
Guidance for Practicing Primary Care
Primary care docs have role to play in hypertension prevention and treatment for women of reproductive age
AHA issues statement concerning hypertension in pregnancy, outlining many prevention and treatment options.
Feature
Uptake uncertain for potent new LDL-lowerer inclisiran
Inclisiran, a novel small interfering RNA drug that inhibits PCSK9, made its U.S. debut in early 2022 with cautious uptake prospects.